価格表

在庫・価格 : 2024年04月28日 07時34分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
HMGB1, Human/Mouse/Rat, ELISA Kit
データシート
ARG81351 ARIアリゴ バイオラボラトリーズ
Arigo Biolaboratories Corp.
1 kit ¥148,000 1個 追加

在庫・価格 : 2024年04月28日 07時34分 現在

HMGB1, Human/Mouse/Rat, ELISA Kit

  • 商品コード:ARG81351
  • メーカー:ARI
  • 包装:1kit
  • 価格: ¥148,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Ogura Y et al. Elevation of circulating neutrophil extracellular traps, interleukin (IL)-8, IL-22, and vascular endothelial growth factor in patients with venomous snake mamushi (Gloydius blomhoffii) bites. J Dermatol 2022 Jan;49(1):124-132
Ogura Y et al
2022/01/01
PubMed
2 Pegylated Liposomal Mitoxantrone Modulates Tumor Immune Landscape to Boost Pd-L1 Blockade Therapy., SSRN

PubMed
3 Ding M et al. MicroRNA-200b-3p as a biomarker for diagnosis and survival prognosis of multiple organ dysfunction syndrome caused by acute paraquat poisoning. Hum Exp Toxicol 2022;41:9603271221094008
Ding M et al
2022/01/01
PubMed
4 Luo J et al. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy. J Nanobiotechnology 2022 May;20(1):228
Luo J et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Ogura Y et al. Elevation of circulating neutrophil extracellular traps, interleukin (IL)-8, IL-22, and vascular endothelial growth factor in patients with venomous snake mamushi (Gloydius blomhoffii) bites. J Dermatol 2022 Jan;49(1):124-132
    Ogura Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Pegylated Liposomal Mitoxantrone Modulates Tumor Immune Landscape to Boost Pd-L1 Blockade Therapy., SSRN

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ding M et al. MicroRNA-200b-3p as a biomarker for diagnosis and survival prognosis of multiple organ dysfunction syndrome caused by acute paraquat poisoning. Hum Exp Toxicol 2022;41:9603271221094008
    Ding M et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Luo J et al. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy. J Nanobiotechnology 2022 May;20(1):228
    Luo J et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed